Valsts: Jaunzēlande
Valoda: angļu
Klimata pārmaiņas: Medsafe (Medicines Safety Authority)
Fluoxetine hydrochloride 5.05 mg/mL equivalent to fluoxetine 4 mg/mL
Eli Lilly and Company (NZ) Limited
N06AB03
Fluoxetine hydrochloride 5.05 mg/mL (equivalent to fluoxetine 4 mg/mL)
4 mg/mL
Oral solution
Active: Fluoxetine hydrochloride 5.05 mg/mL equivalent to fluoxetine 4 mg/mL
Bottle, 70 mL
Prescription
Prescription
Eli Lilly SA
Depression and it's associated anxiety, Bulimia nervosa, Obsessive-Compulsive disorder and Premenstrual dysphoric disorder - a severe form of PMS. Diagnosis of PMDD: The essential features of PMDD are clear and established cyclicity of symptoms (occurring during the last week of the luteal phase in most menstrual cycles) such as depressed mood, anxiety, affective lability, and physical symptoms such as breast tenderness or swelling, headaches, joint or muscle pain, bloating, and weight gain. PMDD is a severe clinical entity and is distinguished from the broader premenstrual syndrome by the intensity of its symptoms (particularly mood symptoms) and the extent to which it interferes with social and/or occupational function
Package - Contents - Shelf Life: Bottle, - 70 mL - 24 months from date of manufacture stored at or below 30°C
1992-04-26